ELZANOR TXR 10/5/1000 TAB

ELZANOR TXR 10/5/1000 TAB is a fixed-dose combination tablet containing empagliflozin, linagliptin, and metformin HCl in extended-release formulation. This triple-action medication is designed for patients with type 2 diabetes who require comprehensive glycemic control. Empagliflozin works by promoting glucose excretion through urine, while linagliptin inhibits DPP-4 to enhance incretin activity. Metformin HCl provides additional glucose regulation through hepatic mechanisms. The extended-release formulation ensures sustained therapeutic levels throughout the day. Suitable for adults with inadequate glycemic control on dual or monotherapy. Each tablet delivers consistent dosing for improved compliance and diabetes management.